Veracyte Announces New Data Highlighting Performance of the Afirma GSC Ensemble Machine Learning Algorithms in Challenging Thyroid Cancer Subtypes to Be Presented at ATA Next-Generation Test is First to Distinguish Benign from Cancerous Hürthle Cells